About this trial
The goal of this clinical trial is to evaluate the evolution of a cardiac ultrasound index (E/E') during 3 spontaneous breathing trials in Intensive Care Unit (ICU) adults (over 18 years) patients at risk for weaning failure. The main objective is to find out which spontaneous breathing trial is the least demanding in terms of heart work.
Investigators will compare 3 consecutive spontaneous breathing trials in a random order to see if one is superior to the others.
Participants will not have to perform any specific procedure apart from breathing without respiratory support during the spontaneous breathing trial. During these trials, the investigator will perform cardiac ultrasound measurements.
Eligibility criteria
Qualifiers
Intubated patient undergoing invasive mechanical ventilation for at least 24 hours and scheduled for a spontaneous breathing trial
Richmond Agitation Sedation Scale (RASS) between -1 and +1
Underlying cardiac disease (left ventricular dysfunction with left ventricular ejection fraction ≤ 45%, documented ischemic heart disease, chronic atrial fibrillation, known history of cardiogenic pulmonary edema)
Underlying respiratory disease (COPD, Emphysema, bronchial dilatation, asthma, obesity/hypoventilation syndrome, restrictive lung disease)
Disqualifiers
Neuromuscular pathology (myasthenia type) preceding hospitalization
Pregnant or breast-feeding women
Patient already included in the study
Protected person (under guardianship or curatorship)
Trial design
Treatments tested in this trial
- No Pressure Support No Positive End Expiratory Pressure Spontaneous Breathing Trial
- Pressure Support Spontaneous Breathing trial
- Humidified High Flow Spontaneous Breathing Trial
Treatment groups
6
Treatment groupsSee each treatment group below.